News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Hagop Kantarjian: A comprehensive review of ponatinib in CML and Ph+ ALL
Photo of Dr. Hagop Kantarjian from obroncology.com
May 19, 2024, 10:00

Hagop Kantarjian: A comprehensive review of ponatinib in CML and Ph+ ALL

Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X:

“A comprehensive review of the research history and current status of ponatinib in CML and Ph+ ALL
Elias Jabbour of MD Anderson Comprehensive Cancer Center.”

Source: Hagop Kantarjian/X

cancer cancer center research cancer therapy cancer treatment CML research comprehensive review current status Elias Jabbour Hagop Kantarjian leukemia professor Leukemia Research MD Anderson Cancer Center OncoDaily Oncology oncology update Ph- ALL ponatinib history ponatinib review
Special Coverage
Insight
Oct 5, 2024, 02:12
Eric K. Singhi: FDA Oncology approves amivantamab and chemo for EGFR and NSCLC
Insight
Oct 5, 2024, 02:08
Supriya Peshin: Reuniting with my mentor is a dream come true
Insight
Oct 5, 2024, 02:01
Leticia Boatman: I win my battle against breast cancer everyday
Societies
Oct 5, 2024, 01:54
Highlights From The AIEOP 2024 Congress
Blog
Oct 5, 2024, 01:51
Matteo Lambertini: Starting Breast Cancer Awareness Month by visiting Hospital Británico
Dialogues
Oct 4, 2024, 21:03
United Against Cancer v1: Luke Thomas and Zainab Shinkafi-Bagudu on Advancing Childhood Cancer Care
Blog
Oct 4, 2024, 19:26
A day of mission-driven impact toward a world without cancer - AIM-HI Accelerator Fund
Blog
Oct 4, 2024, 19:20
The Lancet Oncology Commission presented at ASTRO24 - ESTRO
Blog
Oct 4, 2024, 19:14
Louise Turner - The healer and teacher
Blog
Oct 4, 2024, 17:55
Enhancing Quality of Life and Health Beyond Cancer - Sylvester Comprehensive Cancer Center
Career
Oct 4, 2024, 17:47
Hana Chaar Choueib Is Running For The UICC Board of Directors
Blog
Oct 4, 2024, 17:28
Raffaele Colombo: sBLA for T-DXd has been accepted by FDA HER2-low or HER2-ultralow breast cancer